Dow Up 0.90% Nasdaq Up 1.68%

BioCryst Pharmaceuticals, Inc. (BCRX)

-NasdaqGS
11.44 Down 0.16(1.38%) 12:58PM EDT - Nasdaq Real Time Price
Prev Close:11.60
Open:11.61
Bid:11.45 x 500
Ask:11.46 x 100
1y Target Est:17.73
Beta:3.81
Next Earnings Date: 6-Nov-14BCRX Earnings announcement
Day's Range:11.35 - 11.75
52wk Range:4.55 - 14.62
Volume:505,924
Avg Vol (3m):1,399,910
Market Cap:820.89M
P/E (ttm):N/A
EPS (ttm):-0.64
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Related Video

Featured on Yahoo Finance

Comparison

Symbol% ChgMkt Cap
BCRXDown 1.38%820.89M
GSKUp 0.22%104.98B
RHHBYUp 1.35%246.89B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):46.55
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.83
Quarterly EPS Est (Sep-14) :-0.20
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):-2.04

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small molecule pharmaceuticals that block key enzymes involved in the pathogenesis of diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback